CareDx's AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients
Source: marketscreener.com
Stay updated with breaking news from Appl Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients
Cushing’s syndrome is related to high production of cortisol and, without timely treatment, it can lead to complications such as heart attacks, strokes and type 2 diabetes.
Laboratorians explore how use of the updated estimated glomerular filtration rate equations differs for transgender patients and how to interpret laboratory test results in transgender and nonbinary populations.